Showing results (2201-2210 of 9,924) with videos related to
Sort By:
Pageof 993
Bone Marrow Transplantation|February 19, 2014
In a 12-allele analysis HLA-DPB1 matching is associated with improved OS in leukaemic and myelodysplastic patients receiving myeloablative T-cell-depleted PBSCT from unrelated donorsC Burt, A Parker, G McQuaker, et al.Bone Marrow Transplantation|May 27, 2008
Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipientsS Langner, Pb Staber, N Schub, et al.Bone Marrow Transplantation|May 27, 2008
Lack of utility of chimerism studies obtained 2-3 months after myeloablative hematopoietic cell transplantation for ALLKc Doney, Mr Loken, Em Bryant, et al.Bone Marrow Transplantation|May 27, 2008
Reduced efficacy of topical corticosteroid in preventing cytarabine-induced kerato-conjunctivitis in patients receiving high-dose cytarabine and total body irradiation for allogeneic hematopoietic stem cell transplantationT Mori, M Watanabe, T Kurotori-Sotome, et al.Bone Marrow Transplantation|May 13, 2008
Selection of cord blood unit(s) for transplantationD A Wall, K W ChanBone Marrow Transplantation|May 1, 1989
A monoclonal antibody cocktail for detection of micrometastatic tumor cells in the bone marrow of breast cancer patientsM Taha, N G Ordoñez, S Kulkarni, et al.Bone Marrow Transplantation|March 15, 2019
Antithymocyte globulin improves GVHD-free and relapse-free survival in unrelated hematopoietic stem cell transplantationYi Luo, Mengqi Jin, Yamin Tan, et al.Bone Marrow Transplantation|March 15, 2019
ABO blood type incompatibility lost the unfavorable impact on outcome in unrelated bone marrow transplantationFumihiko Kimura, Junya Kanda, Ken Ishiyama, et al.Bone Marrow Transplantation|March 21, 2019
Donor-derived CD4+/CCR7+ T-cell impact on acute GVHD incidence following haplo-HCT after reduced intensity conditioning and posttransplant cyclophosphamidePauline Varlet, Tamim Alsuliman, Jacques Trauet, et al.Bone Marrow Transplantation|March 21, 2019
Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patientsAngela Granata, Sabine Fürst, Stefania Bramanti, et al.Pageof 993